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After construction of a systemic-to-pulmonary shuntwith an expanded polytetrafluoroethylene (ePTFE)graft, a perigraft seroma may develop as a result ofseepage of serious fluid through the prosthesis.1 In an
effort to prevent this complication, a modified ePTFE pediatric
shunt graft covered with a low-permeability reinforcing film (pore
size 1 m) has been developed (Gore-Tex Vascular Graft Con-
figured for Pediatric Shunt; W. L. Gore & Associates, Inc, Flag-
staff, Ariz). We describe our initial clinical experience with this
graft, focusing on histologic studies performed after explantation.
Patients and Methods
Beginning in 2001, the modified graft was implanted in 13 con-
secutive patients (aged 13 days to 6 years) for construction of a
modified Blalock-Taussig shunt (n 9) or a central shunt from the
ascending aorta to a standard 18-mm ePTFE graft (n  4). The
shunt graft was routinely covered with an ePTFE surgical mem-
brane to avoid adhesions and facilitate its subsequent dissection.
All patients received continuous intravenous infusions of heparin
immediately after surgery. When oral intake resumed, warfarin
and an antiplatelet agent were administered.
Forty-nine to 653 days after implantation, 14 shunt graft spec-
imens (2 from 1 patient) were obtained for histologic analysis at
takedown of the shunt in preparation for additional surgery. In
patients with a central shunt, small pieces of the 18-mm standard
ePTFE graft were removed to tailor it for the inferior caval venous
channel, and these specimens were also analyzed. The histologic
studies included hematoxylin and eosin staining, trichrome stain-
ing, and immunohistochemical assessments for factor VIII (a
marker for endothelium) and smooth muscle actin antigen.
Results
Clinical examinations showed that all shunt grafts remained patent
during use. No seromas were observed on echocardiography, on
chest roentgenography, or during inspection of the graft specimens
From the Department of Cardiovascular Surgery, National Cardiovascular
Center, Osaka, Japan,a the Department of Cardio-thoracic Surgery, Royal
Brompton Hospital, London, United Kingdom,b and W. L. Gore & Asso-
ciates, Inc, Flagstaff, Ariz.
Received for publication March 7, 2005; accepted for publication March 22,
2005.
Address for reprints: Toshikatsu Yagihara, MD, Department of Cardiovas-
cular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita,
Osaka 565-8565, Japan (E-mail: yagihara@hsp.ncvc.go.jp).
J Thorac Cardiovasc Surg 2005;130:934-5
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2005.03.034
Figure 1. Histologic studies of explanted ePTFE grafts. A, Spec-
imen from modified graft used for central shunt, obtained about
201 days after implantation. Proteinaceous fluids are present
within graft interstices (pink) but not outside outer membrane
(upper right). Thin, low-permeability film is visible at ablumen
(arrow). There is no neointimal proliferation along lumen (lower
left; hematoxylin-eosin stain, original magnification 50). B,
Specimen from standard 18-mm ePTFE graft, obtained about 210
days after implantation. Small accumulation of proteinaceous
fluid (asterisk) appears on abluminal surface of graft (hematox-
ylin-eosin stain, original magnification 25).
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at explantation. In the 1 patient who required a second thoracot-
omy to treat persistent chylothorax, no evidence of serous leakage
was observed around the implanted graft at operation.
At harvesting, all shunt graft specimens were macroscopically
patent, and there were no perigraft accumulations of fibrinous
tissue. Microscopy showed that proteinaceous fluid had infiltrated
the interstices of the grafts but had not leaked through the outer
film layer (Figure 1, A). In contrast, 3 of the 4 standard ePTFE
graft specimens showed leakage of fluid through the outer graft
wall (Figure 1, B). In 13 of the 14 shunt graft specimens, the outer
graft surface had no tissue attachment; in the other, the graft was
encapsulated by mature collagenous (trichrome-positive) tissue
(Figure 2). No specimen had evidence of mineralization, diffuse
inflammation, or infection.
No thrombotic tissue was present in the lumen of any of the
shunt grafts, but all had a neointima. The Pearson correlation
coefficient demonstrated no correlation between maximum neoin-
timal thickness and length of time the graft was implanted (r 
0.15). The neointima was composed of circumferentially arranged
spindle cells within a laminar collagen stroma. The lumina were
lined by flattened epithelial cells positive for factor VIII antigen
and consistent with endothelium. Spindle cells containing smooth
muscle actin were located in both the collagenous neointima and
the interstices of the shunt grafts. Collagen fibers had penetrated
the luminal interstices of the grafts.
Discussion
Many factors have been postulated to contribute to perigraft se-
roma formation, including use of heparin,2 inappropriate graft
handling,3 shunt size, and the presence of an inhibitor that prevents
maturation or proliferation of perigraft fibroblasts.4 In our experi-
ence with 150 standard ePTFE pediatric shunts, we observed
important seromas only after complicated procedures such as
pulmonary arterial reconstruction with a heterologous pericardial
roll.5 We therefore assume that persistent high stress on the wall of
a shunt graft is one of the mechanisms of seroma formation.
The histologic findings in this study suggest that the exterior
reinforcing film on the modified ePTFE shunt graft increases
resistance to leakage of proteinaceous fluid through the graft wall.
In contrast, fluid leakage was observed in the explanted standard
ePTFE graft specimens. The data indicate that use of the modified
shunt graft may prevent seroma formation after pediatric shunt
procedures.
A concern pertaining to use of nonporous grafts is that exces-
sive intimal proliferation may eventually result in occlusion of the
lumen by the neointima, especially in small-diameter grafts such as
those used for pediatric shunts. There were no occlusions in the
shunt grafts in our patients, but we cannot rule out the possibility
that occlusion might eventually develop. On the other hand, we
found no correlation between maximum neointimal thickness in
the shunt grafts and duration of implantation. Patients with mod-
ified shunt graft implants should be monitored closely.
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Figure 2. Specimen from explanted modified graft used for Bla-
lock-Taussig shunt. Collagenous neointima (asterisk) lines lu-
men, and collagen fibers penetrate luminal surface. Low-perme-
ability membrane (arrow) is visible at ablumen (trichrome stain,
original magnification 50).
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